Has Veerabhadra Reddy, MD received payments from drug or device companies?

Yes. Drug and device makers reported $59,313 in general payments to Veerabhadra Reddy, MD across 191 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Veerabhadra Reddy, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Veerabhadra Reddy, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Veerabhadra Reddy, MD

Foot and Ankle Surgery · Dallas, TXNPI 1760685705

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $45,210 of the $59,313 with a category attached, or 76.2%. Stryker accounts for 94.3% of it on its own, with 15 other manufacturers making up the rest. 2025 is the largest year on record at $32,111, more than ten times the $1,888 reported in 2019. Among foot and ankle surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$59,313in general payments, 2019–2025

Across 191 payments — averaging $310.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Stryker$56K
Orthofix Medical, Inc.$2K
Pylant Medical$432
International Life Sciences$187
Axogen$141
Integra Lifesciences Corporation$53
plus $286 from 10 others

What the payments were for

Consulting fees$45,21076%
Speaking & faculty fees$4551%
Travel & lodging$5,5939%
Food & beverage$6,81811%
Education$1,2382%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Stryker(2 entities)	154	$55,955
Orthofix Medical, Inc.	8	$2,259
Pylant Medical	8	$432
International Life Sciences	1	$187
Axogen	3	$141
Integra Lifesciences Corporation	2	$53
Endo USA, Inc.	2	$46
Sanofi-aventis U.S. LLC	2	$42
Merck	2	$37
Pacira Therapeutics, Inc.	2	$34
Amgen	2	$33
Avanos Medical	1	$24
Medline Industries LP	1	$23
Bioventus LLC	1	$21
Treace Medical Concepts, Inc.	1	$14
Smith+Nephew	1	$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$59,313 in reported general payments places this provider in the 90th percentile of 684 foot and ankle surgery providers in Texas.

See all foot and ankle surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$188,678

Medicare patients

460

Services billed

2,770

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	69	$792
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	27	$355
Doxycycline Monohydrate	18	$172
Methylprednisolone	13	$103
Tramadol Hcl	31	$87
Meloxicam	13	$31

Paid to pharmacies, not to this prescriber.

Other foot and ankle surgery in Dallas

Eugene CurryDallas$3.1M
Paul KimDallas$928K
John EarlyDallas$553K
Dane WukichDallas$189K
Charles CookDallas$92K
Trapper LalliDallas$74K
John NoackDallas$49K
William McGarveyKaty$3.5M
Graham HamiltonEdinburg$2.1M
Mark DaltonAustin$1.9M

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →